Under the 10th Malaysia Plan (2011–2015), the government has identified healthcare services as one of the 12 National Key Economic Areas (NKEA) to generate revenue for the country. Malaysia now has 8 Joint Commission International (JCI) and 24 Malaysia Society for Quality in Health (MSQH) accredited hospitals, with another 31 hospitals and ambulatory care facilities in the process of becoming accredited.
Market drivers such as rising middle and affluent income population, medical tourism, rise in chronic disease and aging and growing population will impact the healthcare services market, according to Frost & Sullivan. Conversely, market constrains such as medical personnel shortage, discrepancy between urban and rural regions and the inability to meet the demand of healthcare services in towns and rural areas will set the market back.
According to the World Bank health statistics, Malaysia’s spending on healthcare was estimated at 4.4% of its GDP, with government expenditure accounting for 55% of total health expenditure. Private sector services mainly dominate the healthcare industry in Malaysia. Frost & Sullivan estimated the private healthcare sector to generate revenue of MYR 11bn in 2018 from MYR 7bn in 2012, growing at a CAGR of 8.4% during 2012–2018.
Besides, Malaysia is fast becoming the destination of choice for medical tourists behind Thailand and Singapore, driven by affordable costs, specialised hospitals, high-quality medical care and short waiting times. According to the Malaysian Healthcare Travel Council (MHTC), the number of foreign patients seeking medical treatment in Malaysia would expand from the current 600,000 in 2012 to 2 million by 2020.
KPJ Healthcare Berhad is the largest private healthcare operator in the country with more than 2,600 beds across its hospitals or about 21% of the total private sector capacity. The group also has the highest share of patient admissions and the largest number of medical personnel.
• With rapid population growth and rising per capita incomes, Frost & Sullivan predicted Malaysia’s private healthcare sector to expand from MYR 7bn in 2012 to MYR 11bn in 2018, growing at a CAGR of 8.4% during the period.
• Despite low spending on healthcare at 4.4% of its GDP, Malaysia had the second-highest health expenditure per capita in the ASEAN region in 2012 at USD 518.
• According to the MHTC, around 600,000 foreign patients seek medical treatment in Malaysia, generating revenue of nearly MYR 550mn in 2012. Indonesian patients remain as one of its major source, representing about 50% of the revenue and 70% of the arrivals.
Table of Contents
1. Industry profile
1.1 Asia-Pacific overview
1.1.1 Healthcare market
1.1.2 Pharmaceutical market
1.2 Malaysia overview
1.2.1 Healthcare services
1.2.2 Health human resources
1.2.3 Healthcare expenditure
1.2.4 Private sector market size
1.3 Health tourism
1.3.1 Size and value
1.3.2 Treatment costs
1.4 Health insurance
2. Market trends and outlook
2.1 Growth opportunities and market trends
2.2 Industry SWOT
2.3 Healthcare incentives
2.4 Healthcare reforms
3. Leading players and comparative matrix
3.1 Leading players
3.1.1 KPJ Healthcare Berhad
3.1.2 TMC Life Sciences Berhad
3.1.3 Faber Group Berhad
3.2 Comparative matrix
3.3 SWOT analysis
4. Tables and charts
Table 1: Major trends impacting healthcare market opportunities
Table 2: Population and vital statistics (2011 vs. 2001)
Table 3: Admissions and outpatient attendances in 2011
Table 4: Public sector healthcare facilities as of Dec 2011
Table 5: Private sector healthcare facilities as of Dec 2011
Table 6: Medical personnel ratio to population as of Dec 2011
Table 7: Health budget allocation in relation to national budget in 2012
Table 8: Cost comparison of selected medical procedures (in USD)
Table 9: Cost of public hospital treatment for foreign patients
Table 10: JCI accredited medical providers in Malaysia
Table 11: KPJ hospital expansion plans
Table 12: KPJ five-year financial highlights
Table 13: KPJ financials for first quarter ended Mar 31, 2013
Table 14: TMC five-year financial highlights
Table 15: TMC financials for nine-month ended Feb 28, 2013
Table 16: FGB five-year financial highlights
Table 17: FGB financials for first quarter ended Mar 31, 2013
Table 18: Selected peer comparison of key financial ratios
Chart 1: APAC healthcare market revenue (2012-2018)
Chart 2: Global pharmaceutical market by region in 2011
Chart 3: Top 10 causes of death in MOH hospitals
Chart 4: Healthcare industry expenditure in 2012
Chart 5: Total health expenditure as % of GDP (2002-2012)
Chart 6: Healthcare expenditure per capita in APAC (2012-2018)
Chart 7: Private hospitals domestic market share by beds
Chart 8: ASEAN medical tourism market share
Chart 9: Growth of health tourists and receipts (2004–2012)
Chart 10: Malaysian health tourists by nationality (%)
Chart 11: KPJ revenue breakdown
Chart 12: FGB revenue contribution by country
Release Date: Fri, 31 May 2013